dsip danaher Corporation Dana Deasy Named CIO for

While we dont yet have precise human data, BPC-157 appears to be: Rapidly absorbed into circulation Short-acting in plasma , but with longer-lasting biological effects due to downstream healing responses Cleared from the bloodstream in several hours , though effects may persist for days or weeks BPC-157 initiates angiogenic and cytoprotective signaling cascades that extend beyond its direct presence in the bloodstream. Sikiric, P

NAD+ participates in over 400 enzymatic reactions, including the core pathways of energy metabolism, DNA repair, and cellular signaling

BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits

CagriSema (the cagrilintide plus semaglutide combination) has been filed for FDA review and could receive approval by late 2026 or early 2027